Communications Medicine Tightens the Bar for Compound Identity and Purity
Communications Medicine is drawing a firm line on what counts as adequately characterized science. Manuscripts submitted to the journal must now carry enough evidence to support the identity, purity, and homogeneity of chemical and biomolecular materials, not just a claim that a compound worked in an experiment. In practice, that means authors need to do more than name a molecule or cite a synthesis pathway. They need to show the data that makes the structure believable, reproducible, and inspectable by other laboratories.
The policy reaches beyond small molecules. It also extends to biological constructs such as plasmids, fusion proteins, and site-directed mutants, which must be validated with sequencing or functional data in the manuscript text, supplementary information, or methods section. In other words, the journal is treating identity as a scientific endpoint in its own right. A result built on an unverified construct or poorly characterized material can unravel long before a reader reaches the discussion section.
Structural Proof, Not Just Synthesis Claims
For organic and organometallic compounds, identity should be established through spectroscopic analysis. NMR data carry particular weight, and the journal expects copies of spectra for all new and known compounds, with the spectra placed in a supplementary data file rather than buried in the main supplement. When ultraviolet or infrared signals help define a functional group, those data may also be used, and crystalline materials should include melting-point ranges. New compounds need mass spectral support for molecular weight, with high-resolution mass spectrometry preferred.
The requirements are more exacting for compounds whose behavior can mislead even experienced investigators. Chiral materials should have their enantiomeric composition characterized with appropriate methods such as polarimetry, NMR, single-crystal X-ray diffraction, or correlation of HPLC or GC data. The specific rotation should be reported, and the composition may be expressed as enantiomeric excess or ratio. Solid-state compounds, meanwhile, may need solid-state NMR or powder X-ray diffraction, with comparison to calculated patterns where possible. These are not ornamental details. They determine whether the material under study is genuinely the substance described on the page or a mixture that only resembles it under selective conditions.
Purity is handled with the same seriousness. Yield and evidence of sample purity are required for each isolated compound, and the acceptable method depends on the material class. For many small molecules, high-field 1H NMR and 13C NMR can demonstrate purity, while chromatographic or electrophoretic methods may be used for small molecules and polymers. Elemental analysis remains encouraged for organic and organometallic compounds, and crystalline compounds should report melting points. If a species cannot be isolated or fully characterized because it is unstable, a mixture, an intermediate, or available only in small quantity, the manuscript must say so plainly.
NMR Expectations Are Detailed and Non-Negotiable
The NMR section reads like a technical contract between authors and readers. Spectra should cover the full relevant chemical-shift range, include clear labels for compound number, nucleus, solvent, and field strength, and present peaks with readable line thickness and integration. For 1H NMR, chemical shifts should be reported to two decimal places; for proton-decoupled 13C NMR, to one decimal place unless an extra digit is needed to separate overlapping peaks. Coupling constants must be listed, multiplicities must use accepted abbreviations, and the total number of signals should match the expected structure.
Special nuclides receive special attention. Fluorine-containing molecules require 19F NMR or 19F{1H} NMR, while phosphorus-containing compounds require 31P NMR or 31P{1H} NMR. Other nuclei, including lithium, boron, and selenium, may also warrant dedicated spectra. The journal also specifies how spectra should be displayed: one spectrum per A4 page in landscape format, unedited, with appropriate scaling so analyte peaks and solvent peaks remain legible. These expectations reflect a practical concern familiar to any chemist or translational scientist — ambiguous spectral presentation is often the first warning sign that a structure assignment may not survive scrutiny.
A concrete example appears in the guidance itself, including a full characterisation format with melting point, specific rotation, proton and carbon resonances, IR and UV/Vis data, high-resolution mass spectrometry, and elemental analysis. The signal is unmistakable: a paper will be judged not only on the story it tells, but on the quality of the underlying analytical record.
Biological Constructs and Macromolecules Need Their Own Validation
The policy also recognizes that not every research material can be fully handled like a small molecule. For biopolymeric materials such as oligosaccharides, peptides, and nucleic acids, direct structural analysis by NMR may not always be feasible. In those cases, identity should be supported by sequence information when appropriate and by mass spectral characterization. Biological constructs require their own layer of proof, whether through sequencing or functional validation.
That emphasis matters because modern medical research often depends on engineered systems. A plasmid can alter expression, a fusion protein can change localization or binding, and a site-directed mutant can shift the biology under study. If the construct is wrong, the experiment can still produce clean-looking data that point in the wrong direction. The journal’s standards are designed to catch that problem before it becomes part of the published record.
Screening, Microscopy, and Computational Results Also Face Scrutiny
The policy extends beyond chemistry in the narrow sense. Chemical probes, small-molecule high-throughput screening data, microscopy outputs, computational results, and gene nomenclature all fall under the same umbrella of rigor. The message is consistent across formats: if a manuscript claims a material, probe, result, or construct, the supporting evidence must be sufficient for others to evaluate it.
Authors are encouraged to deposit step-by-step experimental protocols on a protocol-sharing platform of their choice, with Nature Portfolio’s Protocol Exchange offered as a free and citable option. For known compounds, the journal prefers references rather than long procedural descriptions unless the method departs from or improves on established practice. That approach pushes the manuscript toward transparency without rewarding redundancy. It also creates a cleaner division between established chemistry and genuinely novel procedure.
The section on reporting standards reinforces the same principle. Data and materials must be available in a form that lets another laboratory test the work, reproduce the synthesis, or verify the structural assignment. The standard is demanding because the downstream consequences are demanding too. When characterization is thin, reproducibility suffers, and a result can look stronger on paper than it is in the bench-top reality of a second laboratory.
Why These Standards Matter for Translational Work
For a journal positioned at the intersection of medicine and mechanistic science, the insistence on complete characterization is more than editorial housekeeping. Biomedical findings often depend on a compound’s exact identity, a construct’s true sequence, or a material’s hidden impurity profile. A mislabeled reagent can distort pharmacology, alter binding behavior, or contaminate a screening pipeline. A poorly documented structure can also obscure negative findings, because other investigators cannot determine whether the same material was actually tested.
The practical consequence is straightforward. Manuscripts that enter Communications Medicine will need to arrive with analytical depth, not just experimental ambition. The journal is asking authors to show their work in a way that withstands expert inspection, and in a field where small structural mistakes can generate large biological errors, that requirement is doing real methodological work.